Risk assessment of probiotics use requires clinical parameters

Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):202-204. doi: 10.1038/s41575-019-0111-4.

Authors

Philippe Langella¹, Jean-Marc Chatel²

Affiliations

¹ Commensal and Probiotics-Host Interactions Laboratory, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, 78350, France. philippe.langella@inra.fr.
² Commensal and Probiotics-Host Interactions Laboratory, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, 78350, France.

PMID: 30692658
DOI: 10.1038/s41575-019-0111-4

No abstract available

Publication types

Comment

MeSH terms

Microbiota*
Probiotics*
Risk Assessment